Third Rock Ventures GP IV, L.P.
Insider CIK 1688326 · RVMD 10% owner · FULC 10% owner · MGTA 10% owner · PLRX 10% owner · RLAY 10% owner · TNGX 10% owner · MAZE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | J Other | 2025-11-04 | 2025-11-05 | 1,600,000 | — | $0 | 4,473,958 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-10-23 | 2025-10-27 | 477,401 | $10.15 | $4.85M | 13,386,574 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-09-25 | 2025-09-29 | 500,000 | $8.02 | $4.01M | 13,863,975 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-09-16 | 2025-09-17 | 363,541 | $7.04 | $2.56M | 14,363,975 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-09-08 | 2025-09-09 | 86,459 | $7.04 | $608.7K | 14,727,516 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-09-05 | 2025-09-09 | 642,906 | $7.00 | $4.50M | 14,813,975 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 302,194 | $7.00 | $2.12M | 15,456,881 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-08-19 | 2025-08-21 | 1,100,000 | $7.01 | $7.71M | 15,759,075 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 9,725,709 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 9,166,666 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 45,833,334 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 5,762,788 | — | $0 | 6,073,958 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 950,800 | — | $0 | 950,800 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-09-13 | 2024-09-17 | 67,400 | $10.53 | $709.7K | 16,859,075 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-09-05 | 2024-09-09 | 75,000 | $11.56 | $867.0K | 16,926,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-08-30 | 2024-09-04 | 175,000 | $11.60 | $2.03M | 17,001,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-29 | 25,000 | $11.55 | $288.8K | 17,176,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 150,000 | $10.09 | $1.51M | 17,201,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-08-16 | 2024-08-20 | 135,000 | $9.79 | $1.32M | 17,351,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-08-01 | 2024-08-01 | 40,000 | $9.80 | $392.0K | 17,486,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-31 | 2024-08-01 | 100,000 | $9.93 | $993.0K | 17,526,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-08-01 | 95,000 | $9.80 | $931.0K | 17,626,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-26 | 2024-07-30 | 50,000 | $9.84 | $492.0K | 17,721,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-25 | 2024-07-26 | 100,599 | $9.87 | $992.9K | 17,771,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-24 | 2024-07-26 | 200,000 | $9.82 | $1.96M | 17,872,074 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-23 | 2024-07-24 | 125,000 | $9.79 | $1.22M | 18,072,074 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-22 | 2024-07-24 | 262,740 | $9.78 | $2.57M | 18,197,074 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-18 | 2024-07-22 | 191,490 | $9.81 | $1.88M | 18,459,814 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-17 | 2024-07-18 | 550,171 | $9.79 | $5.39M | 18,651,304 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-02-20 | 2024-02-21 | 162,500 | $12.00 | $1.95M | 19,201,475 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | S Sale | 2023-02-08 | 2023-02-09 | 1,500,000 | $0.82 | $1.23M | 3,058,204 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | S Sale | 2023-02-07 | 2023-02-09 | 2,200,000 | $0.83 | $1.83M | 4,558,204 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | J Other | 2021-08-25 | 2021-08-26 | 1,250,000 | — | $0 | 6,758,204 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-14 | 2021-01-14 | 1,965,294 | $41.00 | $80.58M | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 7,412 | $44.73 | $331.5K | 7,739,918 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 4,782 | $44.73 | $213.9K | 1,965,294 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 2,791 | $44.00 | $122.8K | 1,970,076 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 27,650 | $42.12 | $1.16M | 1,972,867 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 5,630 | $41.08 | $231.3K | 2,000,517 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 805,050 | $40.01 | $32.21M | 2,006,147 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 4,325 | $44.00 | $190.3K | 7,747,330 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 42,860 | $42.12 | $1.81M | 7,751,655 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 8,727 | $41.08 | $358.5K | 7,794,515 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 1,247,873 | $40.01 | $49.93M | 7,803,242 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-12 | 2021-01-14 | 1,500,000 | $40.00 | $60.00M | 9,051,115 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 61,881 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 61,881 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 9,920,455 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 35,404,286 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 2,793,770 | — | $0 | 2,793,770 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 17,427 | — | $0 | 9,987,881 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 17,427 | — | $0 | 2,811,197 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 9,970,454 | — | $0 | 9,970,454 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 15,250,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 39,750,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 5,559,440 | — | $0 | 5,839,160 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 2,132,867 | — | $0 | 2,132,867 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 342,505 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 49,879 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 1,027,516 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 1,419,900 | — | $0 | 1,419,900 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion deriv | 2019-07-22 | 2019-07-22 | 15,833,333 | — | $0 | 0 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion | 2019-07-22 | 2019-07-22 | 2,261,904 | — | $0 | 2,261,904 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2019-07-22 | 2019-07-22 | 81,250 | $16.00 | $1.30M | 2,343,154 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 340,566 | — | $0 | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 20,102,478 | — | $0 | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 7,911,455 | — | $0 | 8,008,204 | SEC↗ |